Skip to content
Screener

Agilon Health AGL Q3 2025 earnings

Reported November 4, 2025 · After market close

Revenue$1.4BBeat by $13.6M
EPS-$0.27Miss by $0.09
Revenue estimate$1.4B
EPS estimate-$0.18

Next report

Nov 3, 2026 (in 2 months)
Revenue estimate$1.5B
EPS estimate-$1.22

Financials

Q3 2025

Income statement

See full
Revenue$1.4B-1.1%
Operating income-$131.3M+1.7%
Net income-$110.2M+6.3%
EPS (diluted)-$0.27+6.9%

Balance sheet

See full
Cash & equivalents$171.7M+11.6%
Total debt$37.1M-15.4%
Total equity$306.1M-46.8%
Total assets$1.6B-23.7%

Cash flow

See full
Operating cash flow-$18.2M-136%
CapEx$3.2M-10.2%
Free cash flow-$21.3M-89.8%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$426.86M-73.6%
Enterprise value$292.29M-80.6%
P/S0.1×-0.2×

Profitability

See full
Operating margin-6.4%+0.2pp
Net margin-5.2%-1.0pp

Returns & leverage

See full
Return on equity-70%+32.3pp
Debt / equity0.1×0.0×
Current ratio1.1×-0.2×

Segments

By product

See full
Medical services revenue$1.4B-1.1%

FAQ

When did Agilon Health report Q3 2025 earnings?
Agilon Health (AGL) reported Q3 2025 earnings on November 4, 2025 after market close.
What were Agilon Health's Q3 2025 revenue and EPS?
Agilon Health reported revenue of $1.4B and eps of $-0.27 for Q3 2025.
Did Agilon Health beat estimates in Q3 2025?
Revenue beat the consensus estimate of $1.4B by $13.6M. EPS missed the consensus estimate of $-0.18 by $0.09.
How did Agilon Health's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 1.1% from $1.5B a year earlier and eps grew 6.9% from $-0.29.
Where can I find Agilon Health's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001628280-25-048815) and the 10-Q periodic report (0001628280-25-048839) directly on SEC EDGAR. The filing index links above go to sec.gov.